[
  {
    "ts": null,
    "headline": "As insurers axe Medicare plans, here's what advisors should know",
    "summary": "As major insurers reduce Medicare Advantage benefits and exit markets, retirees face higher costs and limited options. Advisors need to understand the implications for retirement planning.",
    "url": "https://finnhub.io/api/news?id=5e172a5db4e9f99556af56827b2e66311395d7212b5ae46eff9a023cdbd609c3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755122608,
      "headline": "As insurers axe Medicare plans, here's what advisors should know",
      "id": 136344954,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "As major insurers reduce Medicare Advantage benefits and exit markets, retirees face higher costs and limited options. Advisors need to understand the implications for retirement planning.",
      "url": "https://finnhub.io/api/news?id=5e172a5db4e9f99556af56827b2e66311395d7212b5ae46eff9a023cdbd609c3"
    }
  },
  {
    "ts": null,
    "headline": "Some Investors May Be Willing To Look Past CVS Health's (NYSE:CVS) Soft Earnings",
    "summary": "NYSE:CVS 1 Year Share Price vs Fair Value Explore CVS Health's Fair Values from the Community and select yours Soft...",
    "url": "https://finnhub.io/api/news?id=c40455b3c7dc21d12a7aff90e473b4d9ee8ec2766a6c97dfae4a7aba4e56c686",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755086669,
      "headline": "Some Investors May Be Willing To Look Past CVS Health's (NYSE:CVS) Soft Earnings",
      "id": 136328495,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "NYSE:CVS 1 Year Share Price vs Fair Value Explore CVS Health's Fair Values from the Community and select yours Soft...",
      "url": "https://finnhub.io/api/news?id=c40455b3c7dc21d12a7aff90e473b4d9ee8ec2766a6c97dfae4a7aba4e56c686"
    }
  },
  {
    "ts": null,
    "headline": "My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys",
    "summary": "See here for more on July's investment insights: record-breaking dividends, high-yield BDCs, and strategies for steady income growth.",
    "url": "https://finnhub.io/api/news?id=642c79a5d7ace207c9d722f9b6e969419b05a47cf1edf5c3505e32f7b283a55b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755072900,
      "headline": "My Dividend Stock Portfolio: New July Dividend Record - 100 Holdings With 12 Buys",
      "id": 136327951,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1213764535/image_1213764535.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "See here for more on July's investment insights: record-breaking dividends, high-yield BDCs, and strategies for steady income growth.",
      "url": "https://finnhub.io/api/news?id=642c79a5d7ace207c9d722f9b6e969419b05a47cf1edf5c3505e32f7b283a55b"
    }
  },
  {
    "ts": null,
    "headline": "CVS Q2 Deep Dive: Pharmacy Strength and Aetna Recovery Drive Guidance Boost",
    "summary": "Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non-GAAP profit of $1.81 per share was 23.9% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=9904f01b5b6d2061c3e20e1fbfc7143becdcb042c23de8a2e80237ccfd27864f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755057963,
      "headline": "CVS Q2 Deep Dive: Pharmacy Strength and Aetna Recovery Drive Guidance Boost",
      "id": 136328496,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "Diversified healthcare company CVS Health (NYSE:CVS) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non-GAAP profit of $1.81 per share was 23.9% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=9904f01b5b6d2061c3e20e1fbfc7143becdcb042c23de8a2e80237ccfd27864f"
    }
  },
  {
    "ts": null,
    "headline": "The 5 Most Interesting Analyst Questions From CVS Health’s Q2 Earnings Call",
    "summary": "CVS Health’s second quarter results surpassed Wall Street’s expectations, with management attributing the outperformance primarily to operational improvements in its Aetna business and continued momentum in pharmacy operations. CEO J. David Joyner highlighted technology-driven process enhancements at Aetna and a focus on customer experience across pharmacy and consumer wellness as key contributors. The company also benefited from market disruption caused by competitor pharmacy closures and succe",
    "url": "https://finnhub.io/api/news?id=2540687f89c3bca120ceedf6105bd656dc72f3147ab36e013500f8b733b5f0b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755057944,
      "headline": "The 5 Most Interesting Analyst Questions From CVS Health’s Q2 Earnings Call",
      "id": 136328497,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health’s second quarter results surpassed Wall Street’s expectations, with management attributing the outperformance primarily to operational improvements in its Aetna business and continued momentum in pharmacy operations. CEO J. David Joyner highlighted technology-driven process enhancements at Aetna and a focus on customer experience across pharmacy and consumer wellness as key contributors. The company also benefited from market disruption caused by competitor pharmacy closures and succe",
      "url": "https://finnhub.io/api/news?id=2540687f89c3bca120ceedf6105bd656dc72f3147ab36e013500f8b733b5f0b0"
    }
  }
]